Nasus Pharma Ltd.

NSRX
$3.50 (- $0.02 - 0.43%)
Last updated: 2026-07-05 04:45 UTC
NSRX Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryDrug Manufacturers - General
ISINN/A
Market Price3.5
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPS-0.18
Market Cap$67.9M
Book Value-0.44
Price to Book-17.202
BetaN/A
52w High9.99
52w Low5.9
Next Earnings DateN/A

Nasus Pharma Ltd. trades under ticker NSRX on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure.

About the Company
Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Price History